Association of subclinical hypothalamic-pituitary-adrenal axis suppression with bone loss in patients with asthma taking inhaled corticosteroids

Annals of Allergy, Asthma and Immunology

Volumn 111, Issue 3, 2013, Pages 229-231

  Kasayama, Soji ^a   Otsuki, Michio ^b   Tanemura, Mari ^c   Fujita, Kimie ^c,d   Miyatake, Akihiko ^c  

^a NISSAY HOSPITAL   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Miyatake Asthma Clinic   (Japan)

^d UNIVERSITY OF SHIGA PREFECTURE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID; FLUORINATED HYDROCARBON; FLUTICASONE PROPIONATE; HYDROCORTISONE;

ADRENAL SUPPRESSION; ADULT; ASTHMA; BONE DENSITY; CORTICOTROPIN TEST; DISEASE ASSOCIATION; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LETTER; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SYNDROME DELINEATION;

EID: 84883447785     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2013.07.001     Document Type: Article

References (10)

1. J. Broide, R. Soferman, and S. Kivity Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids J Clin Endocrinol Metab 80 1995 1243 1246
2. M.C. Raux Demay, J.P. Magny, N. Idres, A. Grimfeld, and Y. Le Bouc Use of the low-dose corticotrophin stimulation test for the monitoring of children with asthma treated with inhaled corticosteroids Horm Res 66 2006 51 60
3. G. Dickstein, C. Shechner, and W.E. Nicholson Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test J Clin Endocrinol Metab 72 1991 773 778
4. K. Tordjman, A. Jaffe, Y. Trostanetsky, Y. Greenman, R. Limor, and N. Stern Low-dose (1 μg) adrenocorticotrophin (ACTH) stimulation as a screening test for impaired hypothalamo-pituitary-adrenal axis function: sensitivity, specificity and accuracy in comparison with the high-dose (250 μg) test Clin Endocrinol (Oxf) 52 2000 633 640
5. E.D. Bateman, S.S. Hurd, and P.J. Barnes Global strategy for asthma management and prevention: GINA executive summary Eur Respir J 31 2008 143 178
6. D.B. Allen, L. Bielory, H. Derendorf, R. Dluhy, G.L. Colice, and S.J. Szefler Inhaled corticosteroids: past lessons and future issues J Allergy Clin Immunol 112 2003 S1 S40
7. L. Patel, J.K. Wales, M.S. Kibirige, A.A. Massarano, J.M. Couriel, and P.E. Clayton Symptomatic adrenal insufficiency during inhaled corticosteroid treatment Arch Dis Child 85 2001 330 334
8. M. Masoli, M. Weatherall, S. Holt, P. Shirtcliffe, and R. Beasley Inhaled fluticasone propionate and adrenal effects in adult asthma: systematic review and meta-analysis Eur Respir J 28 2006 960 967
9. K. Fujita, S. Kasayama, and J. Hashimoto Inhaled corticosteroids reduce bone mineral density in early postmenopausal but not premenopausal asthmatic women J Bone Miner Res 16 2001 782 787
10. C.A. Wong, L.J. Walsh, and C.J. Smith Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men J Clin Endocrinol Metab 91 2006 3908 3915